X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (70) 70
index medicus (67) 67
female (59) 59
male (59) 59
aged (46) 46
rheumatology (42) 42
middle aged (41) 41
rheumatoid arthritis (40) 40
article (33) 33
retrospective studies (31) 31
arthritis, rheumatoid - drug therapy (28) 28
medicare (24) 24
risk factors (24) 24
cohort studies (23) 23
incidence (22) 22
united states - epidemiology (21) 21
tumor necrosis factor-alpha - antagonists & inhibitors (20) 20
abridged index medicus (19) 19
adult (19) 19
aged, 80 and over (19) 19
infliximab (19) 19
antirheumatic agents - therapeutic use (18) 18
united states (18) 18
databases, factual (17) 17
human necessities (17) 17
rheumatoid-arthritis (16) 16
proportional hazards models (15) 15
antirheumatic agents - adverse effects (14) 14
performing operations (14) 14
transporting (14) 14
treatment outcome (14) 14
etanercept (13) 13
health risk assessment (13) 13
risk (13) 13
adalimumab (12) 12
safety (12) 12
infection (11) 11
care and treatment (10) 10
chemistry (10) 10
infections (10) 10
metallurgy (10) 10
therapy (10) 10
drug therapy (9) 9
electroacupuncture (9) 9
follow-up studies (9) 9
herpes zoster - epidemiology (9) 9
hospitalization (9) 9
inflammatory bowel disease (9) 9
mortality (9) 9
research (9) 9
acupuncture (8) 8
adolescent (8) 8
animals (8) 8
arthritis, rheumatoid - complications (8) 8
arthritis, rheumatoid - epidemiology (8) 8
beds (8) 8
chairs (8) 8
coffee mills (8) 8
domestic articles or appliances (8) 8
efficacy (8) 8
furniture (8) 8
gastroenterology and hepatology (8) 8
health aspects (8) 8
hospitalization - statistics & numerical data (8) 8
modifying antirheumatic drugs (8) 8
patients (8) 8
risk assessment (8) 8
sofas (8) 8
spice mills (8) 8
suction cleaners in general (8) 8
surgery (8) 8
vaccination (8) 8
algorithms (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
autoimmune diseases (7) 7
biological products - adverse effects (7) 7
biologics (7) 7
confidence intervals (7) 7
factor-alpha antagonists (7) 7
herpes zoster (7) 7
immunology (7) 7
medicine (7) 7
methotrexate (7) 7
psoriasis (7) 7
research article (7) 7
serious bacterial-infections (7) 7
time factors (7) 7
young adult (7) 7
acupuncture points (6) 6
acupuncture therapy (6) 6
analysis (6) 6
anti-tnf therapy (6) 6
antirheumatic agents - administration & dosage (6) 6
biological products - therapeutic use (6) 6
children (6) 6
complications and side effects (6) 6
disease (6) 6
dosage and administration (6) 6
herpes zoster - prevention & control (6) 6
management (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Zhongguo zhen jiu = Chinese acupuncture & moxibustion, ISSN 0255-2930, 2009, Volume 29, Issue 5, pp. 345 - 348
To investigate the clinical effects of electroacupuncture (EA) at Fenglong (ST 40) on blood lipids. Two hundred and four patients of hyperlipidemia were... 
Hyperlipidemias - blood | Electroacupuncture | Follow-Up Studies | Cholesterol - blood | Humans | Middle Aged | Male | Lipids - blood | Triglycerides - blood | Acupuncture Points | Adult | Female | Aged | Hyperlipidemias - therapy
Journal Article
Zhongguo zhen jiu = Chinese acupuncture & moxibustion, ISSN 0255-2930, 2008, Volume 28, Issue 4, pp. 293 - 296
To probe into the target organ of Fenglong (ST 40) and the mechanism in resolving phlegm. Thirty SD rats were randomly divided into 3 groups, a blank control... 
Electroacupuncture | Hyperlipidemias - metabolism | Liver - metabolism | Rats | Male | Pancreas - metabolism | Rats, Sprague-Dawley | Malondialdehyde - analysis | Animals | Spleen - metabolism | Acupuncture Points | Lung - metabolism | Hyperlipidemias - therapy | Superoxide Dismutase - metabolism
Journal Article
Zhongguo zhen jiu = Chinese acupuncture & moxibustion, ISSN 0255-2930, 2007, Volume 27, Issue 1, pp. 39 - 43
To study the effects of different parameters (frequency, intensity, needle-retained time and treatment interval) of electroacupuncture at Fenglong (ST 40) for... 
Hyperlipidemias - blood | Cholesterol - blood | Humans | Middle Aged | Male | Lipids - blood | Cholesterol, HDL - blood | Acupuncture Points | Cholesterol, LDL - blood | Female | Aged | Hyperlipidemias - therapy | Electroacupuncture - methods
Journal Article
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 01/2016, Volume 68, Issue 1, pp. 56 - 66
Journal Article
Journal Article
ARTHRITIS RESEARCH & THERAPY, ISSN 1478-6354, 12/2019, Volume 21, Issue 1, pp. 285 - 10
Introduction Biosimilar infliximab has the potential for appreciable cost savings compared to its reference biologic, but dose escalation is common and... 
Golimumab | PLACEBO | Dose escalation | ADALIMUMAB | SAFETY | RHEUMATOLOGY | Biosimilar | RATES | Infliximab | Rheumatoid arthritis | ETANERCEPT | ABATACEPT | REMISSION | Competition | Codes | Biological products | Medicare | TNF inhibitors | FDA approval | Patients | Drug dosages | Cost control
Journal Article
Journal Article
JAMA Dermatology, ISSN 2168-6068, 02/2016, Volume 152, Issue 2, pp. 164 - 172
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 12/2017, Volume 69, Issue 12, pp. 1845 - 1854
Objective The optimal timing of tumor necrosis factor antagonists before elective surgery is unknown. This study evaluated the association between infliximab... 
RHEUMATOLOGY BIOLOGICS REGISTER | SURGEON PROCEDURE VOLUME | MODIFYING ANTIRHEUMATIC DRUGS | BACTERIAL-INFECTIONS | PROPENSITY SCORE | ANTITUMOR-NECROSIS-FACTOR | ARTHRITIS PATIENTS | ANTI-TNF THERAPY | STATES MEDICARE POPULATION | RHEUMATOLOGY | POSTOPERATIVE INFECTION | Multivariate Analysis | Glucocorticoids - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Antirheumatic Agents - administration & dosage | United States | Humans | Knee Joint - physiopathology | Hip Prosthesis - adverse effects | Male | Knee Prosthesis - adverse effects | Infliximab - administration & dosage | Infliximab - adverse effects | Knee Joint - surgery | Prosthesis-Related Infections - microbiology | Time Factors | Arthroplasty, Replacement, Knee - instrumentation | Antirheumatic Agents - adverse effects | Female | Prosthesis-Related Infections - diagnosis | Retrospective Studies | Odds Ratio | Glucocorticoids - adverse effects | Drug Administration Schedule | Medicare | Hip Joint - surgery | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Prosthesis-Related Infections - immunology | Arthroplasty, Replacement, Hip - instrumentation | Logistic Models | Treatment Outcome | Chi-Square Distribution | Arthroplasty, Replacement, Hip - adverse effects | Propensity Score | Hip Joint - physiopathology | Aged | Immunocompromised Host | Elective Surgical Procedures | Knee | Inflammatory bowel diseases | Psoriasis | Glucocorticoids | Arthroplasty (knee) | Arthroplasty (hip) | Infections | Antagonists | Arthritis | Hospitalization | Joint surgery | Tumor necrosis factor-α | Joint diseases | Hip | Risk factors | Spondylitis | Infliximab | Intestine | Rheumatoid arthritis | Surgery | Monoclonal antibodies | Ankylosing spondylitis | Geriatrics
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 07/2018, Volume 77, Issue 7, pp. 1012 - 1016
Journal Article